35 GATEHOUSE DRIVE A2, WALTHAM, MA
Market cap: $2.9B (8/14/2024)
Price: $56.99
News, Articles of Incorporation, Bylaws
Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Shareholder votes
News
Annual Report to Security Holders
Announces Corporate Highlights and Financial Results for the First Quarter 2024
Investor Presentation
Announces Corporate Highlights and Financial Results for the Full Year 2023
Q2
Q1
FY 2023
Q3
FY 2022
Notice of Suspension of Duty to File Reports
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
S-8 POS
Automatic Shelf Registration Statement